Stock Fundamentals

AI Research Report

Generate a comprehensive financial analysis report powered by AI

PEVE.JK - Current Price

$600.00

Company Information

Company Name
Penta Valent
Sector
Healthcare
Industry
Pharmaceutical Retailers
Exchange
JK
Currency: IDR
Full Time Employees: 1,481
Phone: 62 21 567 3891
Fiscal Year End: December
Description:

PT. Penta Valent Tbk distributes pharmaceutical products, medical equipment, and consumer products in Indonesia. It operates through Pharmaceutical Products and Consumer Goods segments. The company offers prescription medicinal products; over the counter drug products; medical supporting equipment, such as blood pressure meters, body thermometers, and others; reaction materials, such as blood sugar tests, pregnancy tests, or rapid tests for Covid-19, drug tests, etc.; and food supplements comprising minerals and nutrients. It also provides products for beauty and skin care, including makeup, perfume, skin nutrition, and other products; and daily cleaning and hygiene equipment and supplies, such as soaps, shampoos, toothpastes, roll on, lotions, and others. PT. Penta Valent Tbk was founded in 1968 and is headquartered in Kebon Jeruk, Indonesia.

Address:

Jl. Kedoya Raya No. 33, Kebon Jeruk, Indonesia, 11520

Directors & Officers

Name Title Year Born
Mr. . Sukismo President Director 1954
Mr. Franxiscus Afat Adinata Nursalim Finance Director & Director 1971
Gunawan Hadi Kartono Corporate Secretary 1975

Shares Statistics

Shares Outstanding: 1.77B
Shares Float: 324.88M
% Insiders: 8,160.00%
% Institutions: 8.50%

Valuation Metrics

Enterprise Value: $1,059.38B
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $1,112.34B
EBITDA: $88.09B
Book Value: $187.58
Profit Margin: 1.76%
Operating Margin: 2.62%
ROA (TTM): 4.41%
ROE (TTM): 20.06%
Revenue (TTM): $3,408.43B
Revenue/Share (TTM): $1.96K
Earnings Growth (YOY): 9.60%
Revenue Growth (YOY): 17.60%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

Date EPS Actual EPS Estimate Difference Surprise %
Jun 30, 2023 4.58 N/A N/A N/A
Mar 31, 2023 3.59 N/A N/A N/A

Balance Sheet (Yearly)

Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $7.78B $N/A $1,163.51B $876.52B $286.99B
2023-12-31 $4.49B $N/A $906.74B $674.53B $232.21B
2022-12-31 $N/A $N/A $743.96B $597.16B $146.80B

Watchlist

0

No stocks in watchlist